Related Experiment Video
Updated: Mar 10, 2026

Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
Endonuclease mediated genome editing in drug discovery and development: promises and challenges
1Therapeutic Discovery, Amgen Inc., Thousand Oaks, CA 91320, USA.
Abstract:
Site specific genome editing has been gradually employed in drug discovery and development process over the past few decades. Recent development of CRISPR technology has significantly accelerated the incorporation of genome editing in the bench side to bedside process. In this review, we summarize examples of applications of genome editing in the drug discovery and development process. We also discuss current hurdles and solutions of genome editing.
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
RNA Editing
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Pharmacogenomics: Identification of New Drug Targets
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

